CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 26 filers reported holding CARDIOME PHARMA CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $35,000 | -59.3% | 16,339 | -14.5% | 0.00% | – |
| Q2 2017 | $86,000 | +16.2% | 19,107 | -22.4% | 0.00% | – |
| Q1 2017 | $74,000 | -43.1% | 24,636 | -47.9% | 0.00% | – |
| Q4 2016 | $130,000 | +5.7% | 47,308 | +20.3% | 0.00% | – |
| Q3 2016 | $123,000 | +50.0% | 39,339 | +144.7% | 0.00% | – |
| Q2 2016 | $82,000 | -12.8% | 16,077 | +38.6% | 0.00% | – |
| Q4 2015 | $94,000 | +46.9% | 11,598 | +51.8% | 0.00% | – |
| Q3 2015 | $64,000 | -62.4% | 7,642 | -57.6% | 0.00% | – |
| Q2 2015 | $170,000 | +254.2% | 18,032 | +251.1% | 0.00% | – |
| Q1 2015 | $48,000 | +29.7% | 5,136 | +27.1% | 0.00% | – |
| Q4 2014 | $37,000 | -57.5% | 4,041 | -63.5% | 0.00% | – |
| Q2 2014 | $87,000 | -51.1% | 11,086 | -50.8% | 0.00% | – |
| Q1 2014 | $178,000 | +97.8% | 22,529 | +56.0% | 0.00% | – |
| Q4 2013 | $90,000 | +136.8% | 14,441 | +33.9% | 0.00% | – |
| Q3 2013 | $38,000 | +245.5% | 10,782 | +83.9% | 0.00% | – |
| Q2 2013 | $11,000 | – | 5,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
| Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
| AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
| CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
| Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
| TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
| PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |